The diverse repertoire of ISG15: more intricate than initially thought

참고문헌 (221)

1. Goldstein, G., "Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells", Proc. Natl Acad. Sci. USA, 72, pp.11~15 (1975)
2. van der Veen, A. G., "Ubiquitin-like proteins", Annu. Rev. Biochem, 81, pp.323~357 (2012)
3. Kim, K. I., "ISG15, not just another ubiquitin-like protein", Biochem. Biophys. Res. Commun, 307, pp.431~434 (2003)
4. Jeon, Y. J., "Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15", J. Clin. Invest, 122, pp.2622~2636 (2012)
5. Jeon, Y. J., "ISG15 modification of filamin B negatively regulates the type I interferon-induced JNK signalling pathway", EMBO Rep, 10, pp.374~380 (2009)
6. Perng, Y. -C., "ISG15 in antiviral immunity and beyond", Nat. Rev. Microbiol, 16, pp.423~439 (2018)
7. Farrell, P. J., "Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells", Nature, 279, pp.523~525 (1979)
8. Narasimhan, J., "Crystal structure of the interferon-induced ubiquitin-like protein ISG15", J. Biol. Chem, 280, pp.27356~27365 (2005)
9. Knight, E., "IFN-induced 15-kDa protein is released from human lymphocytes and monocytes", J. Immunol, 146, pp.2280~2284 (1991)
10. D’Cunha, J., "In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine", J. Immunol, 157, pp.4100~4108 (1996)
11. Lai, C., "Mice lacking the ISG15 E1 enzyme UbE1L demonstrate increased susceptibility to both mouse-adapted and non-mouse-adapted influenza B virus infection", J. Virol, 83, pp.1147~1151 (2009)
12. D’Cunha, J., "Immunoregulatory properties of ISG15, an interferon-induced cytokine", Proc. Natl Acad. Sci. USA, 93, pp.211~215 (1996)
13. Padovan, E., "Interferon stimulated gene 15 constitutively produced by melanoma cells induces e-cadherin expression on human dendritic cells", Cancer Res, 62, pp.3453~3458 (2002)
14. Owhashi, M., "Identification of a ubiquitin family protein as a novel neutrophil chemotactic factor", Biochem. Biophys. Res. Commun, 309, pp.533~539 (2003)
15. Zhang, X., "Human intracellular ISG15 prevents interferon-α", β overamplification and auto-inflammation, 2015, pp.517, 89~93
16. Okumura, A., "ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity", Proc. Natl Acad. Sci. USA, 105, pp.3974~3979 (2008)
17. Haas, A. L., "Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin", J. Biol. Chem, 262, pp.11315~11323 (1987)
18. Yuan, W., "Influenza B virus NS1 protein inhibits conjugation of the interferon(IFN)-induced ubiquitin-like ISG15 protein", EMBO J, 20, pp.362~371 (2001)
19. Potter, J. L., "Precursor processing of pro-ISG15", UCRP, an interferon-β-induced ubiquitin-like protein, 1999, pp.274, 25061~25068
20. Zhang, D., "Interferon-stimulated gene 15 and the protein ISGylation system", J. Interferon Cytokine Res, 31, pp.119~130 (2011)
21. Basters, A., "Structural basis of the specificity of USP18 toward ISG15", Nat. Struct. Mol. Biol, 24, pp.270~278 (2017)
22. Daczkowski, C. M., "Structural insights into the interaction of coronavirus papain-like proteases and interferon-stimulated gene product 15 from different species", J. Mol. Biol, 429, pp.1661~1683 (2017)
23. Langley, C., "Structure of interferon-stimulated gene product 15(ISG15)from the bat species Myotis davidii and the impact of interdomain ISG15 interactions on viral protein engagement", Acta Crystallogr. Sect. D. Struct. Biol, 75, pp.21~31 (2019)
24. Sorensen, C. M., "The hinge region between two ubiquitin-like domains destabilizes recombinant ISG15 in solution", Biochemistry, 46, pp.772~780 (2007)
25. Yin, C., "Backbone and Ile-δ1, Leu, Val Methyl 1 H, 13 C and 15 N NMR chemical shift assignments for human interferon-stimulated gene 15 protein", Biomol. NMR Assign, 5, pp.215~219 (2011)
26. Dao, C. T., "ISG15: a ubiquitin-like enigma", Front. Biosci, 10, pp.2701~2722 (2005)
27. Chang, Y. -G., "Different roles for two ubiquitin-like domains of ISG15 in protein modification", J. Biol. Chem, 283, pp.13370~13377 (2008)
28. Park, J. M., "Modification of PCNA by ISG15 plays a crucial role in termination of error-prone translesion DNA synthesis", Mol. Cell, 54, pp.626~638 (2014)
29. Radoshevich, L., "ISG15 counteracts Listeria monocytogenes infection", Elife, 4, pp.e06848~ (2015)
30. Malakhova, O., "Lipopolysaccharide activates the expression of ISG15-specific protease UBP43 via interferon regulatory factor 3", J. Biol. Chem, 277, pp.14703~14711 (2002)
31. Loeb, K. R., "The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins", J. Biol. Chem, 267, pp.7806~7813 (1992)
32. 전영주, "Interferon-Stimulated Gene 15 in the Control of Cellular Responses to Genotoxic Stress", Molecules and Cells, 40(2), pp.83~89 (2017), 한국분자세포생물학회
33. Yeh, Y. -H., "A negative feedback of the HIF-1α pathway via interferon-stimulated gene 15 and ISGylation", Clin. Cancer Res, 19, pp.5927~5939 (2013)
34. Lertsooksawat, W., "Up-regulation of interferon-stimulated gene 15 and its conjugation machinery, UbE1L and UbcH8 expression by tumor necrosis factor-α through p38 MAPK and JNK signaling pathways in human lung carcinoma", Mol. Cell. Biochem, 462, pp.51~59 (2019)
35. Ashley, R. L., "Deletion of the Isg15 gene results in up-regulation of decidual cell survival genes and downregulation of adhesion genes : implication for regulation by IL-1β", Endocrinology, 151, pp.4527~4536 (2010)
36. Tecalco-Cruz, A. C., "Protein ISGylation and free ISG15 levels are increased by interferon gamma in breast cancer cells", Biochem. Biophys. Res. Commun, 499, pp.973~978 (2018)
37. Tecalco-Cruz, A. C., "Interplay between interferon-stimulated gene 15", ISGylation and interferon gamma signaling in breast cancer cells, 2019, pp.54, 91~101
38. Nakka, V. P., "Increased cerebral protein ISGylation after focal ischemia is neuroprotective", J. Cereb. Blood Flow. Metab, 31, pp.2375~2384 (2011)
39. Rossi, J. L., "Interferon-stimulated gene 15 upregulation precedes the development of blood–brain barrier disruption and cerebral edema after traumatic brain injury in young mice", J. Neurotrauma, 32, pp.1101~1108 (2015)
40. Pitha-Rowe, I., "Involvement of UBE1L in ISG15conjugation during retinoid-induced differentiation of acute promyelocytic leukemia", J. Biol. Chem, 279, pp.18178~18187 (2004)
41. Reich, N., "Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element", Proc. Natl Acad. Sci. USA, 84, pp.6394~6398 (1987)
42. Au, W. -C., "Identification of a member of the interferon regulatory factor family that binds to the interferonstimulated response element and activates expression of interferon-induced genes", Proc. Natl Acad. Sci. USA, 92, pp.11657~11661 (1995)
43. Daly, C., "Characterization of specific DNA-binding factors activated by double-stranded RNA as positive regulators of interferon α", β-stimulated genes, 1995, pp.270, 23739~23746
44. Weaver, B. K., "Interferon regulatory factor 3 and CREBbinding protein", p300 are subunits of double-stranded RNA-activated transcription factor DRAF1, 1998, pp.18, 1359~1368
45. Meraro, D., "IFN-stimulated gene 15 is synergistically activated through interactions between the myelocyte", lymphocyte-specific transcription factors, PU. 1, IFN regulatory factor-8, J. Immunol, pp.2002, 168[DOI]
46. Zhao, M., "Comparative transcriptomic and proteomic analyses prove that IFN-λ1 is a more potent inducer of ISGs than IFN-α against porcine epidemic diarrhea virus in porcine intestinal epithelial cells", J. Proteome Res, 19, pp.3697~3707 (2020)
47. Zhao, J., "Porcine interferon lambda 3(IFN-λ3)shows potent anti-PRRSV activity in primary porcine alveolar macrophages(PAMs)", BMC Vet. Res, 16, pp.1~7 (2020)
48. Mossman, K. L., "Herpes simplex virus triggers and then disarms a host antiviral response", J. Virol, 75, pp.750~758 (2001)
49. Hamerman, J. A., "Serpin 2a is induced in activated macrophages and conjugates to a ubiquitin homolog", J. Immunol, 168, pp.2415~2423 (2002)
50. Kim, K. I., "Enhanced antibacterial potential in UBP43-deficient mice against Salmonella typhimurium infection by up-regulating type I IFN signaling", J. Immunol, 175, pp.847~854 (2005)
51. Lenschow, D. J., "Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo", J. Virol, 79, pp.13974~13983 (2005)
52. Kitareewan, S., "UBE1L is a retinoid target that triggers PML", RARα degradation and apoptosis in acute promyelocytic leukemia, 2002, pp.99, 3806~3811
53. Yang, L., "Gene expression profiling during all-trans retinoic acid-induced cell differentiation of acute promyelocytic leukemia cells", J. Mol. Diagn, 5, pp.212~221 (2003)
54. Gianni, M., "Stat1 is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cells", Blood, 89, pp.1001~1012 (1997)
55. Hermann, M. -R., "Integrins synergise to induce expression of the MRTFA–SRF target gene ISG15 for promoting cancer cell invasion", J. Cell Sci, 129, pp.1391~1403 (2016)
56. Brown, A. R., "Krüppel-like factor 9(KLF9)prevents colorectal cancer through inhibition of interferon-related signaling", Carcinogenesis, 36, pp.946~955 (2015)
57. 박영신, "CYP1B1 Activates Wnt", β-Catenin Signaling through Suppression of Herc5-Mediated ISGylation for Protein Degradation on β-Catenin in HeLa Cells, 2017, pp.33(3), 211~218[DOI]
58. Zhang, Q., "Roles of miR‑138 and ISG15 in oral squamous cell carcinoma", Exp. Ther. Med, 14, pp.2329~2334 (2017)
59. Liu, Z., "miR-370 regulates ISG15 expression and influences IFN-α sensitivity in hepatocellular carcinoma cells", Cancer Biomark, 22, pp.453~466 (2018)
60. Ayub, S. G., "miR-2909 regulates ISGylation system via STAT1 signalling through negative regulation of SOCS3 in prostate cancer", Andrology, 5, pp.790~797 (2017)
61. Li, X. -Y., "BAG3 deletion suppresses stem cell-like features of pancreatic ductal adenocarcinoma via translational suppression of ISG15", Biochim. Biophys. Acta Mol. Cell Res, 1866, pp.819~827 (2019)
62. Kim, W., "Systematic and quantitative assessment of the ubiquitin-modified proteome", Mol. Cell, 44, pp.325~340 (2011)
63. Zhao, C., "The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-α", β-induced ubiquitin-like protein, 2004, pp.101, 7578~7582
64. Kim, K. I., "Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation", Mol. Cell. Biol, 24, pp.9592~9600 (2004)
65. Durfee, L. A., "The basis for selective E1-E2interactions in the ISG15 conjugation system", J. Biol. Chem, 283, pp.23895~23902 (2008)
66. Zou, W., "The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase", J. Biol. Chem, 281, pp.3989~3994 (2006)
67. Zou, W., "Negative regulation of ISG15 E3 ligase EFP through its autoISGylation", Biochem. Biophys. Res. Commun, 354, pp.321~327 (2007)
68. Okumura, F., "ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP", Genes Dev, 21, pp.255~260 (2007)
69. Dastur, A., "Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells", J. Biol. Chem, 281, pp.4334~4338 (2006)
70. Wong, J. J. Y., "HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets", Proc. Natl Acad. Sci. USA, 103, pp.10735~10740 (2006)
71. Malakhov, M. P., "UBP43(USP18) specifically removes ISG15 from conjugated proteins", J. Biol. Chem, 277, pp.9976~9981 (2002)
72. Li, X. -L., "RNase-L-dependent destabilization of Interferon-induced mRNAs A role for the 2–5A system in attenuation of the interferon response", J. Biol. Chem, 275, pp.8880~8888 (2000)
73. François-Newton, V., "USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response", PLoS ONE, 6, pp.e22200~ (2011)
74. Li, L., "Suppression of USP18potentiates the anti-HBV activity of interferon alpha in HepG2. 2.15 cells via JAK", STAT signaling, 2016, pp.11, e0156496~
75. MacParland, S. A., "Lipopolysaccharide and tumor necrosis factor alpha inhibit interferon signaling in hepatocytes by increasing ubiquitin-like protease 18(USP18)expression", J. Virol, 90, pp.5549~5560 (2016)
76. Yang, Z., "USP18 negatively regulates NF-κB signaling by targeting TAK1 and NEMO for deubiquitination through distinct mechanisms", Sci. Rep, 5, pp.12738~ (2015)
77. Dieterich, C., "Modulation of the host interferon response and ISGylation pathway by B. pertussis filamentous hemagglutinin", PLoS ONE, 6, pp.e27535~ (2011)
78. Colonne, P. M., "Rickettsia conorii infection stimulates the expression of ISG15 and ISG15 protease UBP43 in human microvascular endothelial cells", Biochem. Biophys. Res. Commun, 416, pp.153~158 (2011)
79. Colonne, P. M., "Suppressor of cytokine signalling protein SOCS1 and UBP43 regulate the expression of type I interferon-stimulated genes in human microvascular endothelial cells infected with Rickettsia conorii", J. Med. Microbiol, 62, pp.968~979 (2013)
80. Liu, L. -Q., "A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hematopoietic cell differentiation", Mol. Cell. Biol, 19, pp.3029~3038 (1999)
81. Schwer, H., "Cloning and characterization of a novel human ubiquitinspecific protease, a homologue of murine UBP43(Usp18)", Genomics, 65, pp.44~52 (2000)
82. Malakhova, O. A., "UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity", EMBO J, 25, pp.2358~2367 (2006)
83. Basters, A., "Molecular characterization of ubiquitin-specific protease 18reveals substrate specificity for interferon-stimulated gene 15", FEBS J, 281, pp.1918~1928 (2014)
84. Kang, J. A., "Emerging roles of USP18 : From biology to pathophysiology", Int. J. Mol. Sci, 21, pp.6825~ (2020)
85. Liu, X., "USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1–TAB1 complex", J. Exp. Med, 210, pp.1575~1590 (2013)
86. Cai, X., "USP18 deubiquitinates and stabilizes Twist1 to promote epithelialmesenchymal transition in glioblastoma cells", Am. J. Cancer Res, 10, pp.1156~1169 (2020)
87. Vuillier, F., "USP18 and ISG15 coordinately impact on SKP2 and cell cycle progression", Sci. Rep, 9, pp.1~11 (2019)
88. Knight, E., "A 15-kDa interferon-induced protein is derived by COOHterminal processing of a 17-kDa precursor", J. Biol. Chem, 263, pp.4520~4522 (1988)
89. Bogunovic, D., "Mycobacterial disease and impaired IFN-γ immunity in humans with inherited ISG15 deficiency", Science, 337, pp.1684~1688 (2012)
90. Sun, L., "Exosomes contribute to the transmission of anti-HIV activity from TLR3-activated brain microvascular endothelial cells to macrophages", Antivir. Res, 134, pp.167~171 (2016)
91. Swaim, C. D., "Extracellular ISG15 signals cytokine secretion through the LFA-1 integrin receptor", Mol. Cell, 68, pp.581~590.e585 (2017)
92. Napolitano, A., "Cysteine-reactive free ISG15 generates IL-1β–producing CD8α+ dendritic cells at the site of infection", J. Immunol, 201, pp.604~614 (2018)
93. Care, M. A., "Network analysis identifies proinflammatory plasma cell polarization for secretion of ISG15 in human autoimmunity", J. Immunol, 197, pp.1447~1459 (2016)
94. Recht, M., "A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma", J. Immunol, 147, pp.2617~2623 (1991)
95. Dos Santos, P. F., "ISG15-induced IL-10 is a novel anti-inflammatory myeloid axis disrupted during active tuberculosis", J. Immunol, 200, pp.1434~1442 (2018)
96. Thery, F., "Ring finger protein 213 assembles into a sensor for ISGylated proteins with antimicrobial activity", Nat. Commun, 12, pp.1~21 (2021)
97. Giannakopoulos, N. V., "Proteomic identification of proteins conjugated to ISG15 in mouse and human cells", Biochem. Biophys. Res. Commun, 336, pp.496~506 (2005)
98. Zhao, C., "Human ISG15conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways", Proc. Natl Acad. Sci. USA, 102, pp.10200~10205 (2005)
99. Malakhov, M. P., "High-throughput immunoblotting : ubiquitin-like protein ISG15 modifies key regulators of signal transduction", J. Biol. Chem, 278, pp.16608~16613 (2003)
100. Yan, S., "IRF3 reduces adipose thermogenesis via ISG15-mediated reprogramming of glycolysis", J. Ciln. Invest, 131, pp.e144888~ (2021)
101. Zhang, Y., "The in vivo ISGylome links ISG15 to metabolic pathways and autophagy upon Listeria monocytogenes infection", Nat. Commun, 10, pp.1~15 (2019)
102. Takeuchi, T., "Identification and Herc5-mediated ISGylation of novel target proteins", Biochem. Biophys. Res. Commun, 348, pp.473~477 (2006)
103. Lou, Z., "Telomere length regulates ISG15 expression in human cells", Aging, 1, pp.608~621 (2009)
104. Robin, J. D., "Telomere position effect: regulation of gene expression with progressive telomere shortening over long distances", Genes Dev, 28, pp.2464~2476 (2014)
105. Hirashima, K., "Telomeric repeat-containing RNA", G-quadruplexforming sequences cause genome-wide alteration of gene expression in human cancer cells in vivo, 2015, pp.43, 2022~2032
106. Raso, M. C., "Interferon-stimulated gene 15 accelerates replication fork progression inducing chromosomal breakage", J. Cell Biol, 219, pp.e202002175~ (2020)
107. Coquel, F., "SAMHD1 acts at stalled replication forks to prevent interferon induction", Nature, 557, pp.57~61 (2018)
108. Jiang, M., "cGAS-STING, an important pathway in cancer immunotherapy", J. Hematol. Oncol, 13, pp.1~11 (2020)
109. Khodarev, N. N., "STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells", Proc. Natl Acad. Sci. USA, 101, pp.1714~1719 (2004)
110. Weichselbaum, R. R., "An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer", Proc. Natl Acad. Sci. USA, 105, pp.18490~18495 (2008)
111. Fornai, C., "Rapid changes in hepatitis C virus quasispecies produced by a single dose of IFN-α in chronically infected patients", J. Interferon Cytokine Res, 21, pp.417~422 (2001)
112. Sirota, N. P., "Modifying effect in vivo of interferon α on induction and repair of lesions in DNA of lymphoid cells of gamma-irradiated mice", Radiat. Res, 146, pp.100~105 (1996)
113. Boelens, M. C., "Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways", Cell, 159, pp.499~513 (2014)
114. Okumura, F., "Activation of double-stranded RNA-activated protein kinase(PKR)by interferon-stimulated gene 15(ISG15)modification down-regulates protein translation", J. Biol. Chem, 288, pp.2839~2847 (2013)
115. Holthaus, D., "Direct antiviral activity of IFN-stimulated genes is responsible for resistance to paramyxoviruses in ISG15-deficient cells", J. Immunol, 205, pp.261~271 (2020)
116. Wang, J. -M., "ISG15 suppresses translation of ABCC2 via ISGylation of hnRNPA2B1 and enhances drug sensitivity in cisplatin resistant ovarian cancer cells", Biochim. Biophys. Acta Mol. Cell Res, 1867, pp.118647~ (2020)
117. Durfee, L. A., "The ISG15 conjugation system broadly targets newly synthesized proteins : implications for the antiviral function of ISG15", Mol. Cell, 38, pp.722~732 (2010)
118. Held, T., "Evidence for an involvement of the ubiquitin-like modifier ISG15 in MHC class I antigen presentation", Eur. J. Immunol, 51, pp.138~150 (2021)
119. Zhao, C., "Influenza B virus non-structural protein 1 counteracts ISG15antiviral activity by sequestering ISGylated viral proteins", Nat. Commun, 7, pp.1~12 (2016)
120. Rahnefeld, A., "Ubiquitin-like protein ISG15(interferon-stimulated gene of 15 kDa)in host defense against heart failure in a mouse model of virus-induced cardiomyopathy", Circulation, 130, pp.1589~1600 (2014)
121. Liu, M., "Proteasomes modulate conjugation to the ubiquitin-like protein, ISG15", J. Biol. Chem, 278, pp.1594~1602 (2003)
122. Wood, L. M., "A novel role for ATM in regulating proteasome-mediated protein degradation through suppression of the ISG15 conjugation pathway", PLoS ONE, 6, pp.e16422~ (2011)
123. Shi, H. -X., "Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification", Mol. Cell. Biol, 30, pp.2424~2436 (2010)
124. Ganesan, M., "Acetaldehyde disrupts interferon alpha signaling in hepatitis C virus-infected liver cells by up-regulating USP 18", Alcohol. Clin. Exp. Res, 40, pp.2329~2338 (2016)
125. Desai, S. D., "Elevated expression of ISG15 in tumor cells interferes with the ubiquitin", 26S proteasome pathway, 2006, pp.66, 921~928
126. Fan, J. -B., "Identification and characterization of a novel ISG15-ubiquitin mixed chain and its role in regulating protein homeostasis", Sci. Rep, 5, pp.12704~ (2015)
127. Malakhova, O. A., "ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response", J. Biol. Chem, 283, pp.8783~8787 (2008)
128. Wang, B., "FOXO3a is stabilized by USP18-mediated de-ISGylation and inhibits TGF-β1-induced fibronectin expression", J. Invest. Med, 68, pp.786~791 (2020)
129. Lee, J. H., "Glycoprotein 90K, downregulated in advanced colorectal cancer tissues, interacts with CD9", CD82 and suppresses the Wnt, Gut, pp.2010, 59[DOI]
130. Kim, M. -J., "Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation", J. Virol, 82, pp.1474~1483 (2008)
131. Liu, G., "ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity", Nat. Microbiol, 6, pp.467~478 (2021)
132. Yoo, L., "Covalent ISG15 conjugation to CHIP promotes its ubiquitin E3 ligase activity and inhibits lung cancer cell growth in response to type I interferon", Cell Death Dis, 9, pp.97~ (2018)
133. Im, E., "Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin", Open Biol, 6, pp.160193~ (2016)
134. Osei Kuffour, E., "ISG15 deficiency enhances HIV-1 infection by accumulating misfolded p53", mBio, 10, pp.e01342~01319 (2019)
135. Huang, Y. -F., "Oncogene-mediated regulation of p53 ISGylation and functions", Oncotarget, 5, pp.5808~5818 (2014)
136. Kim, K. I., "Ube1L and protein ISGylation are not essential for alpha", beta interferon signaling, 2006, pp.26, 472~479
137. Nixon, R. A., "The role of autophagy in neurodegenerative disease", Nat. Med, 19, pp.983~997 (2013)
138. Desai, S. D., "ISG15 deregulates autophagy in genotoxin-treated ataxia telangiectasia cells", J. Biol. Chem, 288, pp.2388~2402 (2013)
139. Nakashima, H., "ISG15 and ISG-15 linked proteins can associate with members of the selective autophagic process, HDAC6 and SQSTM1", p62, 2014, pp.290, 1485~1495
140. Kawaguchi, Y., "The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress", Cell, 115, pp.727~738 (2003)
141. Lee, J. Y., "HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy", EMBO J, 29, pp.969~980 (2010)
142. Adapala, N. S., "Inflammatory osteolysis is regulated by site-specific ISGylation of the scaffold protein NEMO", Elife, 9, pp.e56095~ (2020)
143. Villarroya-Beltri, C., "ISGylation controls exosome secretion by promoting lysosomal degradation of MVB proteins", Nat. Commun, 7, pp.13588~ (2016)
144. Blanchard, N., "TCR activation of human T cells induces the production of exosomes bearing the TCR", CD3, J. Immunol, pp.2002, 168[DOI]
145. Van der Vlist, E. J., "CD4+ T cell activation promotes the differential release of distinct populations of nanosized vesicles", J. Extracell. Vesicles, 1, pp.18364~ (2012)
146. Andreola, G., "Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles", J. Exp. Med, 195, pp.1303~1316 (2002)
147. Théry, C., "Indirect activation of naïve CD4+ T cells by dendritic cell–derived exosomes", Nat. Immunol, 3, pp.1156~1162 (2002)
148. Chalmin, F., "Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells", J. Clin. Invest, 120, pp.457~471 (2010)
149. Peinado, H., "Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET", Nat. Med, 18, pp.883~891 (2012)
150. Bhushan, J., "ISG15 connects autophagy and IFN-γ-dependent control of Toxoplasma gondii infection in human cells", mBio, 11, pp.e00852~00820 (2020)
151. Du, Y., "LRRC25 inhibits type I IFN signaling by targeting ISG15-associated RIG-I for autophagic degradation", EMBO J, 37, pp.351~366 (2018)
152. Xian, H., "LRRC59 modulates type I interferon signaling by restraining the SQSTM1", p62-mediated autophagic degradation of pattern recognition receptor DDX58, Autophagy, pp.2020, 16[DOI]
153. Baldanta, S., "ISG15 governs mitochondrial function in macrophages following vaccinia virus infection", PLoS Pathog, 13, pp.e1006651~ (2017)
154. Xu, D., "Modification of BECN1 by ISG15 plays a crucial role in autophagy regulation by type I IFN", interferon, 2015, pp.11, 617~628
155. Abrahamsen, H., "Ubiquitination and phosphorylation of Beclin 1 and its binding partners : Tuning class III phosphatidylinositol 3-kinase activity and tumor suppression", FEBS Lett, 586, pp.1584~1591 (2012)
156. Jin, J., "Induced TRIM21 ISGylation by IFN-βenhances p62 ubiquitination to prevent its autophagosome targeting", Cell Death Dis, 12, pp.1~11 (2021)
157. Juncker, M., "ISG15 attenuates post-translational modifications of mitofusins and congression of damaged mitochondria in Ataxia Telangiectasia cells", Biochim. Biophys. Acta Mol. Basis Dis, 1867, pp.166102~ (2021)
158. Bebington, C., "Localization of ubiquitin and ubiquitin cross-reactive protein in human and baboon endometrium and decidua during the menstrual cycle and early pregnancy", Biol. Reprod, 60, pp.920~928 (1999)
159. Yang, L., "Up-regulation of expression of interferon-stimulated gene 15 in the bovine corpus luteum during early pregnancy", J. Dairy Sci, 93, pp.1000~1011 (2010)
160. Joyce, M. M., "Interferon stimulated gene 15 conjugates to endometrial cytosolic proteins and is expressed at the uterine-placental interface throughout pregnancy in sheep", Endocrinology, 146, pp.675~684 (2005)
161. Johnson, G., "Conceptus-uterus interactions in pigs : endometrial gene expression in response to estrogens and interferons from conceptuses", Soc. Reprod. Fertil. Suppl, 66, pp.321~332 (2009)
162. Schanz, A., "Interferon stimulated gene 15 expression at the human embryo-maternal interface", Arch. Gynecol. Obstet, 290, pp.783~789 (2014)
163. Rempel, L. A., "Ubp43 gene expression is required for normal Isg15expression and fetal development", Reprod. Biol. Endocrinol, 5, pp.1~15 (2007)
164. Henkes, L. E., "Embryo mortality in Isg15-", -mice is exacerbated by environmental stress, 2015, pp.92, 31~10
165. Maragno, A. L., "ISG15 modulates development of the erythroid lineage", PLoS ONE, 6, pp.e26068~ (2011)
166. Cong, X.-L., "Usp18 promotes conventional CD11b+ dendritic cell development", J. Immunol, 188, pp.4776~4781 (2012)
167. Cong, X., "Hematopoietic cells from Ube1Ldeficient mice exhibit an impaired proliferation defect under the stress of bone marrow transplantation", Blood Cells Mol. Dis, 45, pp.103~111 (2010)
168. Wu, S. -F., "RIG-I regulates myeloid differentiation by promoting TRIM25-mediated ISGylation", Proc. Natl Acad. Sci. USA, 117, pp.14395~14404 (2020)
169. Kespohl, M., "Protein modification with ISG15 blocks coxsackievirus pathology by antiviral and metabolic reprogramming", Sci. Adv, 6, pp.eaay1109~ (2020)
170. Alcalá, S., "ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity", Nat. Commun, 11, pp.1~17 (2020)
171. Martin-Fernandez, M., "Systemic type I IFN inflammation in human ISG15deficiency leads to necrotizing skin lesions", Cell Rep, 31, pp.107633~ (2020)
172. Speer, S. D., "ISG15 deficiency and increased viral resistance in humans but not mice", Nat. Commun, 7, pp.1~10 (2016)
173. Marié, I. J., "HDAC stimulates gene expression through BRD4 availability in response to IFN and in interferonopathies", J. Exp. Med, 215, pp.3194~3212 (2018)
174. Tokarz, S., "The ISG15 isopeptidase UBP43 is regulated by proteolysis via the SCFSkp2 ubiquitin ligase", J. Biol. Chem, 279, pp.46424~46430 (2004)
175. Arimoto, K. -i, "STAT2 is an essential adaptor in USP18-mediated suppression of type I interferon signaling", Nat. Struct. Mol. Biol, 24, pp.279~289 (2017)
176. Meuwissen, M. E., "Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome", J. Exp. Med, 213, pp.1163~1174 (2016)
177. Kimmey, J. M., "The impact of ISGylation during Mycobacterium tuberculosis infection in mice", Microbes Infect, 19, pp.249~258 (2017)
178. Pacella, I., "ISG15 protects human Tregs from interferon alpha-induced contraction in a cell-intrinsic fashion", Clin. Transl. Immunol, 9, pp.e1221~ (2020)
179. Desai, S. D., "ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells", Exp. Biol. Med, 237, pp.38~49 (2012)
180. Han, H. G., "ISG15 in cancer : beyond ubiquitin-like protein", Cancer Lett, 438, pp.52~62 (2018)
181. Patel, S. A., "Combination cancer therapy with immune checkpoint blockade : mechanisms and strategies", Immunity, 48, pp.417~433 (2018)
182. Feng, Q., "UBE1L causes lung cancer growth suppression by targeting cyclin D1", Mol. Cancer Ther, 7, pp.3780~3788 (2008)
183. Yin, X., "Deficiency of a potential 3p21. 3 tumor suppressor gene UBE1L (UBA7) does not accelerate lung cancer development in K-rasLA2 mice", Lung Cancer, 63, pp.194~200 (2009)
184. Yin, X., "Alteration of tumor spectrum by ISGylation in p53-deficient mice", Cancer Biol. Ther, 8, pp.1167~1172 (2009)
185. Burks, J., "ISGylation governs the oncogenic function of Ki-Ras in breast cancer", Oncogene, 33, pp.794~803 (2014)
186. Chen, Y. -L., "Interferon-stimulated gene 15 modulates cell migration by interacting with Rac1 and contributes to lymph node metastasis of oral squamous cell carcinoma cells", Oncogene, 38, pp.4480~4495 (2019)
187. Bektas, N., "The ubiquitin-like molecule interferon-stimulated gene 15(ISG15)is a potential prognostic marker in human breast cancer", Breast Cancer Res, 10, pp.1~12 (2008)
188. Cruz, A. C. T., "Cell type-dependent regulation of free ISG15levels and ISGylation", J. Cell Commun. Signal, 11, pp.127~135 (2017)
189. Bolado-Carrancio, A., "ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling", Oncogene, 40, pp.6235~6247 (2021)
190. NIu, X. L., "Autocrine interferon-γ may affect malignant behavior and sensitivity to tamoxifen of MCF-7 via estrogen receptor β subtype", Oncol. Rep, 34, pp.3120~3130 (2015)
191. Ning, Y., "IFNγ restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-κB, BCL2 family members, and signaling to caspase-dependent apoptosis", Mol. Cancer Ther, 9, pp.1274~1285 (2010)
192. Forys, J. T., "ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis", Cell Rep, 7, pp.514~526 (2014)
193. Hadjivasiliou, A., "ISG15 implicated in cytoskeleton disruption and promotion of breast cancer", Expert Rev. Proteom, 9, pp.7~ (2012)
194. Cerikan, B., "DOCK6 inactivation highlights ISGylation as RHOGTPase balancer", Cell Cycle, 16, pp.304~305 (2017)
195. Cui, X. -F., "Retinoic acidinducible gene-I is induced by interferon-γ and regulates the expression of interferon-γ stimulated gene 15 in MCF-7 cells", Biochem. Cell Biol, 82, pp.401~405 (2004)
196. Cruz-Ramos, E., "Non-muscle myosin IIA is post-translationally modified by interferon-stimulated gene 15 in breast cancer cells", Int. J. Biochem. Cell Biol, 107, pp.14~26 (2019)
197. Lo, P. -K., "LIPG signaling promotes tumor initiation and metastasis of human basal-like triple-negative breast cancer", eLife, 7, pp.e31334~ (2018)
198. Qiu, X., "ISG15 as a novel prognostic biomarker for hepatitis B virus-related hepatocellular carcinoma", Int. J. Clin. Exp. Med, 8, pp.17140~17150 (2015)
199. Fan, J. -B., "Type I IFN induces protein ISGylation to enhance cytokine expression and augments colonic inflammation", Proc. Natl Acad. Sci. USA, 112, pp.14313~14318 (2015)
200. Kim, S. T., "Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer", Cancer Genomics Proteom, 11, pp.259~266 (2014)
201. Tao, J., "Prognostic value of ISG15 mRNA level in drinkers with esophageal squamous cell cancers", Int. J. Clin. Exp. Pathol, 8, pp.10975~10984 (2015)
202. Jinawath, N., "Comparison of gene-expression profiles between diffuse-and intestinal-type gastric cancers using a genome-wide cDNA microarray", Oncogene, 23, pp.6830~6844 (2004)
203. Shen, J., "A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer", J. Transl. Med, 11, pp.73~ (2013)
204. Kong, E., "Deleting key autophagy elongation proteins induces acquirement of tumor-associated phenotypes via ISG15", Cell Death Differ, 27, pp.2517~2530 (2020)
205. Zhou, M. -J., "ISG15 inhibits cancer cell growth and promotes apoptosis", Int. J. Mol. Med, 39, pp.446~452 (2017)
206. Mao, H., "Interferon-stimulated gene 15 induces cancer cell death by suppressing the NF-κB signaling pathway", Oncotarget, 7, pp.70143~70151 (2016)
207. Yeung, T. -L., "ISG15 promotes ERK1 ISGylation, CD8+ T cell activation and suppresses ovarian cancer progression", Cancers, 10, pp.464~ (2018)
208. Qu, T., "ISG15 induces ESRP1 to inhibit lung adenocarcinoma progression", Cell Death Dis, 11, pp.1~16 (2020)
209. Yuan, H., "ISG15 promotes esophageal squamous cell carcinoma tumorigenesis via c-MET", Fyn, Exp. Cell Res, pp.2018, 367[DOI]
210. Sainz, B., "ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells", Cancer Res, 74, pp.7309~7320 (2014)
211. Sun, J., "Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation", Oncogene, 39, pp.546~559 (2020)
212. Chen, R. -H., "Tumor cell-secreted ISG15 promotes tumor cell migration and immune suppression by inducing the macrophage M2-like phenotype", Front. Immunol, 11, pp.594775~ (2020)
213. Fan, J. -B., "Type I interferon regulates a coordinated gene network to enhance cytotoxic T cell–mediated tumor killing", Cancer Discov, 10, pp.382~393 (2020)
214. Villarreal, D. O., "Ubiquitin-like molecule ISG15 acts as an immune adjuvant to enhance antigen-specific CD8 T-cell tumor immunity", Mol. Ther, 23, pp.1653~1662 (2015)
215. Iglesias-Guimarais, V., "IFN-stimulated gene 15 is an alarmin that boosts the CTL response via an innate, NK cell–dependent route", J. Immunol, 204, pp.2110~2121 (2020)
216. Chun, J. H., "Increased expression of metallothionein is associated with irinotecan resistance in gastric cancer", Cancer Res, 64, pp.4703~4706 (2004)
217. Park, J. H., "Positive feedback regulation of p53 transactivity by DNA damage-induced ISG15 modification", Nat. Commun, 7, pp.12513~ (2016)
218. Roulois, D., "DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts", Cell, 162, pp.961~973 (2015)
219. Ina, S., "Identifying molecular markers for chemosensitivity to gemcitabine in pancreatic cancer : increased expression of interferon-stimulated gene 15 kd is associated with intrinsic chemoresistance", Pancreas, 39, pp.473~485 (2010)
220. Wood, L. M., "The ubiquitin-like protein, ISG15, is a novel tumor-associated antigen for cancer immunotherapy", Cancer Immunol. Immunother, 61, pp.689~700 (2012)
221. Zhou, S., "Inhibition of ISG15 enhances the anti-cancer effect of trametinib in colon cancer cells", OncoTargets Ther, 12, pp.10239~10250 (2019)

관련 논문AI추천